Skip to main content
Premium Trial:

Request an Annual Quote

Ambion to Supply Wyeth with RNA

SAN FRANCISCO, Oct. 4 - Ambion's diagnostic division will develop and manufacture RNA for Wyeth, the company said today.

 

Austin, Texas-based Ambion RNA Diagnostics will optimize processes for synthesizing long RNA molecules and translation into protein, and manufacture the cGMP-grade RNA transcripts for Wyeth's use in its vaccine program, the company said.

 

Financial details of the agreement were not disclosed.

 

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.